Hormone receptor status and survival of medullary breast cancer patients
Authors:
Open Access
- 1 February 2017
- journal article
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 38 (2) , 156-162
Abstract
Hormone receptor status and survival of medullary breast cancer patients. A Turkish cohortKeywords
This publication has 33 references indexed in Scilit:
- Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma SubtypesMedicine, 2015
- Prediction of Breast Cancer Risk Based on Profiling With Common Genetic VariantsJNCI: Journal of the National Cancer Institute, 2015
- Tumor-associated inflammation as a potential prognostic tool in BRCA1/2-associated breast cancerHuman Pathology, 2015
- [Medullary carcinoma experience in breast oncology unit of Hospital Juarez Mexico].2014
- Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or lessThe Breast, 2014
- Clinicopathologic Characteristics of Typical Medullary Breast Carcinoma: A Retrospective Study of 117 CasesPLOS ONE, 2014
- Clinicopathologic features of triple negative breast cancers: an experience from PakistanDiagnostic Pathology, 2014
- Spontaneous Regression of a Conjunctival Malignant MelanomaOrbit, 2013
- Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the OutcomeClinical Breast Cancer, 2013
- Breast cancer in very young womenEuropean Journal of Surgical Oncology, 2011